Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

PDF) Recommendations of the French Society for Rheumatology. TNFα

Canadian Rheumatology Association Meeting Quebec City Convention

PDF) Effect of Biologics in Subgroups of Axial Spondyloarthritis

Frontiers Targeted Therapies in Axial Psoriatic Arthritis

PDF) Work Disability in Axial Spondyloarthritis

Disease activity measurements and monitoring in psoriatic

Outcome measures used in psoriatic arthritis registries and

Safety Profile, Axial Spondyloarthritis

Impact of Achieving ASDAS LDA on Disease Activity and Patient